BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 28987633)

  • 1. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
    Qiu L; Tang Q; Li G; Chen K
    Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications.
    Niu ZS; Niu XJ; Wang WH
    World J Gastroenterol; 2017 Aug; 23(32):5860-5874. PubMed ID: 28932078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs: critical players in hepatocellular carcinoma.
    Sun J; Bie B; Zhang S; Yang J; Li Z
    Int J Mol Sci; 2014 Nov; 15(11):20434-48. PubMed ID: 25387074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
    Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
    Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects.
    Bao H; Su H
    Biomed Res Int; 2017; 2017():6049480. PubMed ID: 28835896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.
    Lanzafame M; Bianco G; Terracciano LM; Ng CKY; Piscuoglio S
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Regulation, Functions, and Underlying Mechanisms.
    Qiu L; Wang T; Xu X; Wu Y; Tang Q; Chen K
    Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29168767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated long non-coding RNA LOC90784 promotes cell proliferation and invasion and is associated with poor clinical features in HCC.
    Xu JH; Chang WH; Fu HW; Shu WQ; Yuan T; Chen P
    Biochem Biophys Res Commun; 2017 Aug; 490(3):920-926. PubMed ID: 28651931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.
    El Khodiry A; Afify M; El Tayebi HM
    World J Gastroenterol; 2018 Feb; 24(5):549-572. PubMed ID: 29434445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
    Qiu L; Xu H; Ji M; Shang D; Lu Z; Wu Y; Tu Z; Liu H
    Life Sci; 2019 Aug; 231():116660. PubMed ID: 31319086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of Long Non-Coding RNA PlncRNA-1 Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
    Dong L; Ni J; Hu W; Yu C; Li H
    Cell Physiol Biochem; 2016; 38(2):836-46. PubMed ID: 26906068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.
    Koduru SV; Leberfinger AN; Kawasawa YI; Mahajan M; Gusani NJ; Sanyal AJ; Ravnic DJ
    Sci Rep; 2018 May; 8(1):7967. PubMed ID: 29789629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
    Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
    Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.